Global Export Business of Finished Pharmaceutical Products

Business Scope and Service Details

The company is fully responsible for overseas compliance registration, international certification declaration, global brand promotion, channel network construction and full-process export sales of the full series of finished pharmaceutical products of SSY Group.

The core covered categories and services include:

1. Full Dosage Form Product Matrix: Full category of injections including large volume parenterals, small volume injections, lyophilized powder for injection, surgical irrigation solutions; solid preparations including tablets, capsules, granules; biological products and characteristic specialized preparations in the fields of anti-infection, antipyretic and analgesic, cardiovascular, digestive system, and anesthesia, covering the core clinical treatment areas.

2. Full-process Supporting Services: Provide one-stop services including marketing authorization declaration in target markets, international standard compliance adaptation, customized packaging and insert design, cross-border cold chain warehousing and logistics, full-cycle technical support, after-sales quality traceability and adverse reaction monitoring.

Core Support: Group's Industrial Advantages

1. Industry-leading Production Capacity Advantage: The Group's annual production capacity of injections reaches 3 billion bottles/bags, with its production scale and technical level ranking among the top in China. It can stably undertake large-volume, long-cycle and multi-batch order deliveries worldwide, without fear of peak season capacity fluctuations and urgent order demands.

2. Internationally Aligned Quality Control System: The Group's production bases have fully passed China NMPA GMP certification, and a number of core products have obtained international authoritative certifications such as EU CEP, US FDA, and WHO-PQ. We fully implement the standards of the International Council for Harmonisation (ICH), and the product quality is benchmarked against the world's leading pharmaceutical enterprises.

3. Full-chain R&D and Industrialization Capability: The Group has built a complete R&D system of "new drug creation, generic drug consistency evaluation, and characteristic preparation industrialization", with a national-level enterprise technology center. It can quickly respond to the customized R&D and production needs of overseas markets for dosage forms, specifications and indications.

4. Proven Global Market Foundation: The Group's finished pharmaceutical products have been stably exported to more than 100 countries and regions around the world, forming extensive brand reputation, complete distributor network and mature terminal cooperation foundation in core markets such as Africa, Southeast Asia, the Middle East, the European Union and the CIS.

Global Customer Value

Global medical institutions, pharmaceutical distributors, public procurement alliances and chain pharmacies can directly obtain: full dosage form preparations with the same quality as the mainstream European and American markets, stable and guaranteed large-volume delivery capacity, one-stop compliance support for international registration and declaration, and a full life cycle quality control system in line with ICH/WHO standards.